PLx Pharma Inc.
SPARTA, NJ · Founded 2010 · CIK 0001497504 · Medtech · Defunct
Oral formulations of existing pharmaceutical APIs using proprietary gastric-protective coating technology
dipexiumpharmaceuticals.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $64M
- 8 Form D · Nov 2020
- 70 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2009201120132015201720192021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,070,000 | |
| Private capital raised | Form D · SEC | $507,500 | |
| Private capital raised | Form D · SEC | $930,000 | |
| Private capital raised | Form D · SEC | $2,750,000 | |
| Private capital raised | Form D · SEC | $18,191,869 | |
| Private capital raised | Form D · SEC | $15,000,000 | |
| Private capital raised | Form D · SEC | $8,000,000 | |
| Private capital raised | Form D · SEC | $18,008,599 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 996 | QUARKSEN LLC | — | — |
| 997 | bioProtonics, LLC | — | $6.4M |
| 998 | Vibrant Composites Inc. | — | $1.4M |
| 999 | PLx Pharma Inc. | — | $64M |
| 1000 | MULTIVARIATE SYSTEMS, INC. | — | — |
| 1001 | LED Technologies Inc. | — | $1.1M |
| 1002 | Lumafield | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Gary BalkemaDirector
- Anthony BartshDirector
- Kirk CalhounDirector
- Robert CasaleDirector
- Christopher CoughlinDirector
- Jack DeanDirector
- Efthymios DeliargyrisExecutive Officer
- Robert DeLucciaDirector · Executive Officer · Promoter
- Michael DuffyDirector
- Natasha GiordanoDirector · Executive Officer
- John HaddenDirector
- John Hadden IIDirector
- Steven HurdDirector
- David JordenExecutive Officer
- Milos KoterecDirector
- John LeoneDirector
- David LuciDirector · Executive Officer · Promoter
- William McSherry, Jr.Director
- Gary MossmanExecutive Officer
- Rita O'ConnorExecutive Officer
- John TerranaDirector
- Michael ValentinoDirector · Executive Officer
- Ellen ZaroffDirector
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.